2017
DOI: 10.1002/cmdc.201700572
|View full text |Cite
|
Sign up to set email alerts
|

Mimicking Intermolecular Interactions of Tight Protein–Protein Complexes for Small‐Molecule Antagonists

Abstract: Tight protein-protein interactions (Kd < 100 nM) that occur over a large binding interface (> 1,000 Å2) are highly challenging to disrupt with small molecules. Historically, the design of small molecules to inhibit protein-protein interactions has focused on mimicking the position of interface protein ligand side chains. Here, we explore mimicry of the pairwise intermolecular interactions of the native protein ligand with residues of the protein receptor to enrich commercial libraries for small-molecule inhibi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
39
1

Year Published

2018
2018
2020
2020

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 14 publications
(43 citation statements)
references
References 55 publications
(87 reference statements)
3
39
1
Order By: Relevance
“…Glide was used to score the Vina-dockedb inding modes in place using the Gli-deHTVS scoring function. [59,60] Ligand pharmacophore:Apreviously described [13] pharmacophore-based approach was adapted and used to identify how docking compounds overlapped with and mimicked known hot spots of the protein ligand in each of the protein-protein complexes.Aset of pharmacophore hypotheses was constructed corresponding to the physicochemical properties of the protein ligand side chain using the Phase package in Schrçdinger. [61,62] Phase has six built-in types of pharmacophore features:1 )hydrogen-bond acceptor( A);2 )hydrogen-bond donor( D);3 )hydrophobe (H);4 )negative ionizable (N);5 )positive ionizable (P);a nd 6) aromaticr ing (R).…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…Glide was used to score the Vina-dockedb inding modes in place using the Gli-deHTVS scoring function. [59,60] Ligand pharmacophore:Apreviously described [13] pharmacophore-based approach was adapted and used to identify how docking compounds overlapped with and mimicked known hot spots of the protein ligand in each of the protein-protein complexes.Aset of pharmacophore hypotheses was constructed corresponding to the physicochemical properties of the protein ligand side chain using the Phase package in Schrçdinger. [61,62] Phase has six built-in types of pharmacophore features:1 )hydrogen-bond acceptor( A);2 )hydrogen-bond donor( D);3 )hydrophobe (H);4 )negative ionizable (N);5 )positive ionizable (P);a nd 6) aromaticr ing (R).…”
Section: Methodsmentioning
confidence: 99%
“…There is growing interest in applying computational methods for the discovery of small‐molecule PPI inhibitors, particularly for tight secondary and tertiary interactions. We have successfully used virtual screening to identify inhibitors of the tight tertiary interaction between the urokinase receptor uPAR and its protein ligand uPA with compounds ranging from sub‐micromolar to micromolar affinity . In one case, we screened multiple structures that were sampled from explicit‐solvent molecular‐dynamics simulations and identified a sub‐micromolar affinity compound .…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Assays used to monitor the effects of small molecules on uPA⋅uPAR tend to test for parameters such as cell migration and invasion to reflect influence on metastatic spread; the work of Meroueh and co‐workers on testing small molecules discovered by virtual screening on the same target was a good model for our studies …”
Section: Figurementioning
confidence: 99%